HIGHLIGHTS
- who: Moses B. Chilombe and colleagues from the Computational Biology, University of Rochester, Rochester, New York, United States of America have published the research work: Aggressive antipyretics in central nervous system malaria: Study protocol of a randomized-controlled trial assessing antipyretic efficacy and parasite clearance effects (Malaria FEVER study), in the Journal: PLOS ONE of 27/04/2022
- what: No later than three years from the close of the study, the authors will deliver a completely de-identified data set to an appropriate data archive for sharing purposes. Prolonged hospitalization potentially related to the study . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.